After bashing him, Turing Pharmaceuticals CEO Martin Shkreli donated money to Sen. Bernie Sanders’ (I-VT) presidential campaign — only to be rebuffed, Stat reported.
“We are not keeping the money from this poster boy for drug company greed,” said campaign spokesperson Michael Briggs.
Instead, Briggs said, the $2,700 Shkreli donated — the maximum individual donation allowed under electoral guidelines — will be given to the Whitman-Walker health clinic in Washington.
Shkreli, who was hit with widespread criticism last month after he raised the price for the medication Daraprim from $13.50 a pill to $750 a pill, told Stat that he backs some of Sanders’ other policy proposals, but made the donation because he wanted to meet with him privately and “explain” how pharmaceutical companies set their prices. He also said that he would ask the senator what prices he would consider fair.
“I’d ask him, what role does innovation play in health care?” Shkreli said. “Is he willing to sort of accept that there is a tradeoff, that to take risks for innovation, companies have to invest lots of money and they need some kind of return for that, and what does he think that should look like?”
Last week, Shkreli accused Sanders of being “misinformed” and “relying on soundbytes and cheap shots” in his criticism of the pharmaceutical industry.
However, Sanders’ campaign has indicated that the Democratic presidential hopeful will not meet with Shkreli.